Useful documents

In this section you can download a set of useful documents that we have selected for you!

You will recognize the different file formats through the icon
that distinguishes them.

DateTitleFile
07/05/10PRESS RELEASE: Lung Cancer Sufferers Should Not Be Blamed For The Diseasescarica
07/05/10Global Perceptions of Lung Cancer GLLCscarica
07/05/10PRESS RELEASE GLCC PEOPLE LIVING WITH LUNG CANCER ARE TOO OFTEN STIGMATISED BECAUSE OF LINK TO SMOKING scarica
06/25/10The Forum Against Cancer Europe Show Your Face Against Cancer: Making Cancer an EU Priorityscarica
05/11/10Lung Cancer Rates soaring in Women, including Non Smokersscarica
05/06/10Data presented at IASLC-ESMO 2nd European Lung Cancer Conference highlight benefits in quality of life (QoL) with first-line use of IRESSA (gefitinib) in EGFR mutation-positive advanced NSCLCscarica
03/11/10Pfizer Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancerscarica
05/03/09Women vulnerable to tobacco carginogensscarica
04/15/09Targeted Therapies in Lung Cancer scarica
11/19/08Solitary fibrous tumour of pleura associated with hypoglycemia (Y.Stojsic)scarica
10/22/08UICC final report World Congress 2008scarica
10/21/08Bevacizumabscarica
10/06/08EUROPEAN CHARTER OF PATIENTS´ RIGHTSscarica
09/29/08From MedScape Today: EGFR Inhibitors: Toxicities and Strategies for Effective Management(Megan Dunne, Dyana K. Sumner)scarica
09/29/08From MedScape Today: Treatment Decision-Making in a Patient With Advanced NSCLC - Howard (Jack) Westscarica
09/29/08From MedScape Today: Targeted Therapies in Lung Cancer (Alan B. Sandler) scarica
09/29/08From MedScape Today: Management of Mesothelioma (Ramaswamy Govindan)scarica
09/29/08From Medscape Today: Evolving Data on EGFR Inhibition in Advanced NSCLC: An Expert Interview With Dr. Edward Kimscarica
09/22/08Histologic Considerations in Selecting Therapy for NSCLC: An Expert Interview With Dr. Chandra P. Belaniscarica
09/01/08Lung cancer in Serbian women (Dr. J. Stojsic, Dr. I. Milovanovic, Dr. J. Radojicic, Dr.B. Milenkovic )scarica
08/29/08EGFR Inhibitors: Toxicities and Strategies for Effective Managementscarica
08/22/08Histological classificationsscarica
07/31/08Lung carcinoma: macroscopic and microscopic aspectsscarica
07/31/08Histological types (Dr. M. Longo)scarica
07/31/08Asthenia (Dr. M.Longo)scarica
07/24/08Lung Cancer in US Women: A Contemporary Epidemicscarica
07/24/08Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 casesscarica
07/24/08Lung Cancer in Women: Emerging Differences in Epidemiology, Biology, and Therapyscarica
07/24/08Women's Susceptibility to Tobacco Carcinogens and Survival After Diagnosis of Lung Cancerscarica
07/24/08Environmental tobacco smoke and lung cancer in nonsmoking women. A multicenter studyscarica
07/24/08Women and Lung Cancer: Gender Equality at a Crossroad?scarica
07/23/08Anaemia (Dr. M. Longo)scarica
07/23/08Nausea and Vomiting (Dr. T. VavalĂ )scarica
07/23/08Staging system for lung cancer (Dr. M. Longo)scarica
07/23/08Bone metastases and diphosphonates (Dr. E. Capelletto)scarica
07/14/08Increased Prevalence of EFGR-Mutant Lung Cancer in Women and in East Asian Populations: Analysis of Estrogen-Related Polymorphismscarica
07/09/08Sex differences in patients with NSCLCscarica
07/09/08Studies_in_NSCLC (Dr.S. Novello)scarica
05/01/08High_Dietary_Inorganic_Phosphate_Increases_Lungscarica
02/21/08Tea age old beverage as an effective cancer chemopreventive agentscarica